Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: A systematic review and practice guideline

Lung Cancer

Volumn 44, Issue 1, 2004, Pages 1-11

  Okawara, Gordon ^a   Ung, Yee Chung ^b   Markman, Barbara R ^c   Mackay, Jean A ^c   Evans, William K ^d   Alam, Yasmin ^e   Brundage, Michael ^e   Dar, A R ^e   Darling, Gail ^e   Dixon, Peter ^e   Ellis, Peter ^e   Falkson, Conrad ^e   Feld, Ronald ^e   Goss, Glen ^e   Graham, Ian ^e   Gregg, Richard ^e   Kocha, Walter ^e   Kotalik, Jaro ^e   Lochrin, Catherine ^e   Laurie, Scott ^e   Logan, Diane ^e   Lopez, Pedro ^e   MacRae, Robert ^e   Malthaner, Richard ^e   Maziak, Donna ^e   Meng, Joanne ^e   Miller, John ^e   Noble, Jonathan ^e   Shepherd, Frances ^e   Stewart, David ^e   Urschel, John ^e   Vincent, Mark ^e   Yu, Edward ^e   more..

^a JURAVINSKI CANCER CENTRE   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d CANCER CARE ONTARIO   (Canada)

^e NONE

Author keywords

Adjuvant therapy; Non small cell lung cancer; Practice guideline; Radiation therapy; Treatment guideline

Indexed keywords

CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RANDOMIZATION; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; META-ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 12144289855     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.09.020     Document Type: Review

References (14)

1. Logan DM, Lochrin CA, Darling G, Eady A, Newman, TE, Evans WK, and the Provincial Lung Cancer Disease Site Group. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small cell lung cancer after complete resection. Cancer Prev Control 1997;1:366-78.
2. Browman G.P., Levine M.N., Mohide E.A., Hayward R.S.A., Pritchard K.I., Gafni A.et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J. Clin. Oncol. 13:1995;502-512.
3. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998;352:257-63.
4. van Houtte P., Rocmans P., Smets P., Goffin J.C., Lustman- Maréchal J., Vanderhoeft P.et al. Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int. J. Radiat. Oncol. Biol. Phys. 6:1980;983-986.
5. Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1986; 315:1377-81.
6. Wang M, Gu XZ, Yin WB, et al. Randomised clinical trial of post-operative irradiation after surgery for non-small cell lung carcinoma. Chin J Radiat Oncol 1994;3:39-43 [cited by [3]].
7. Debevec M., Bitenc M., Vidmar S., Rott T., Orel J., Strojan P.et al. Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): randomised clinical study 1988-1992. Lung Cancer. 14:1996;99-107.
8. Lafitte J.J., Ribet M.E., Prévost B.M., Gosselin B.H., Copin M.C., Brichet A.H.et al. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study. Ann. Thorac. Surg. 62:1996;830-834.
9. Stephens RJ, Girling DJ, Bleehen NM, Moghissi K, Yosef HMA, Machin D, on behalf of the Medical Research Council Lung Cancer Working Party. The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Br J Cancer 1996;74:632-9.
10. Mayer R., Smolle-Juettner F.M., Szolar D., Stuecklschweiger G.F., Quehenberger F., Friehs G.et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest. 112:1997;954-959.
11. Feng Q.F., Wang M., Wang L.J., Yang Z.Y., Zhang Y.G., Zhang D.W.et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 47:2000;925-929.
12. Dautzenberg B., Arriagada R., Chammard A.B., Jarema A., Mezzetti M., Mattson K.et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer. 86:1999;265-273.
13. Munro A.J. What now for postoperative radiotherapy for lung cancer? Lancet. 352:1998;250-251.
14. Machtay M., Lee J.H., Shrager J.B., Kaiser L.R., Glatstein E. Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J. Clin. Oncol. 19:2001;3912-3917.